KRYS

Krystal Biotech Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 8/10
  • Momentum↑ 8/10
Krystal Biotech sales and earnings growth
KRYS Growth
Good
  • Revenue Y/Y↑ 33.94%
  • EPS Y/Y↑ 126.92%
  • FCF Y/Y↑ 58.87%
Krystal Biotech gross and profit margin trends
KRYS Profitability
Great
  • Gross margin ↑ 94.10%
  • EPS margin↑ 52.60%
  • ROIC↑ 26.00%
Krystal Biotech net debt vs free cash flow
KRYS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Krystal Biotech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗